IFPE (Invisalign First Palatal Expander)
Launched by UNIVERSITY OF BRITISH COLUMBIA · Jan 19, 2024
Trial Information
Current as of April 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The IFPE (Invisalign First Palatal Expander) clinical trial is studying a new type of removable dental appliance designed to help children and teens with narrow upper jaws. This condition often leads to issues with how teeth fit together, known as malocclusions. The researchers want to see how well this new expander works compared to traditional methods by gathering feedback from patients and measuring changes in the mouth's structure. This information will help them understand if this new device is effective for early orthodontic treatment.
To participate in the trial, patients must be in the mixed dentition stage (which means they have both baby and adult teeth), with specific teeth present in their upper jaw. They should also have a narrow upper jaw, which may show signs like a crossbite or a certain measurement related to tooth spacing. Participants will be closely monitored throughout the study to assess how the new expander affects their dental and overall jaw structure. It’s important to note that individuals with certain dental issues or previous orthodontic treatments may not be eligible for this trial.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients in mixed dentition with 6 present on both Right and Left in the upper arch
- • Patients with transverse maxillary deficiency (presence of unilateral or bilateral crossbite, or intermolar width (as measured where the palatal groove meets the gingival margin of the first molar) of 33 mm or less)
- Exclusion Criteria:
- • multiple and/or advanced caries,
- • missing teeth due to aplasia, trauma, or deep caries,
- • supernumerary teeth,
- • congenital craniofacial malformations or congenital or acquired systematic disease,
- • previous orthodontic treatment
About University Of British Columbia
The University of British Columbia (UBC) is a leading research institution located in Vancouver, Canada, renowned for its commitment to advancing health sciences through innovative research and education. As a prominent clinical trial sponsor, UBC leverages its interdisciplinary expertise and state-of-the-art facilities to conduct rigorous clinical studies aimed at improving patient outcomes across various medical fields. The university fosters collaborations with healthcare professionals, industry partners, and community stakeholders to translate research findings into practical applications, thereby contributing to the global advancement of medicine and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported